Laurie B. Owen‐Schaub

5.0k total citations · 1 hit paper
52 papers, 4.2k citations indexed

About

Laurie B. Owen‐Schaub is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Laurie B. Owen‐Schaub has authored 52 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 24 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Laurie B. Owen‐Schaub's work include Cell death mechanisms and regulation (20 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (15 papers). Laurie B. Owen‐Schaub is often cited by papers focused on Cell death mechanisms and regulation (20 papers), Immune Cell Function and Interaction (15 papers) and Immunotherapy and Immune Responses (15 papers). Laurie B. Owen‐Schaub collaborates with scholars based in United States, Australia and Japan. Laurie B. Owen‐Schaub's co-authors include Elizabeth A. Grimm, Shin Yonehara, William L. Crump, Robert Radinsky, Sybil M. Santee, Ewa Kruzel, Laurie L. Hill, Jack A. Roth, David Bartos and James C. Cusack and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Laurie B. Owen‐Schaub

51 papers receiving 4.1k citations

Hit Papers

Wild-Type Human p53 and a Temperature-Sensitive Mutant In... 1995 2026 2005 2015 1995 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurie B. Owen‐Schaub United States 32 2.4k 1.6k 1.6k 586 410 52 4.2k
Cornelius Miething Germany 28 3.0k 1.2× 1.2k 0.7× 1.5k 1.0× 740 1.3× 236 0.6× 68 5.1k
C D Bucana United States 40 2.7k 1.1× 1.3k 0.8× 2.0k 1.3× 1.2k 2.0× 321 0.8× 81 5.7k
Colette Adida France 21 3.6k 1.5× 1.0k 0.6× 1.8k 1.2× 750 1.3× 253 0.6× 24 5.2k
Daryl T. Baldwin United States 9 2.5k 1.1× 2.0k 1.3× 824 0.5× 915 1.6× 126 0.3× 10 3.9k
Noelyn M. Kljavin United States 24 1.5k 0.6× 1.8k 1.1× 1.3k 0.8× 432 0.7× 94 0.2× 29 4.1k
Beverly Plunkett United States 18 3.8k 1.6× 633 0.4× 3.7k 2.4× 1.0k 1.7× 1.0k 2.5× 22 5.9k
Molly Kulesz‐Martin United States 29 1.7k 0.7× 633 0.4× 1.1k 0.7× 511 0.9× 211 0.5× 84 2.8k
R W Craig United States 9 3.5k 1.5× 489 0.3× 2.8k 1.8× 844 1.4× 651 1.6× 11 5.1k
HP Koeffler United States 44 3.1k 1.3× 1.6k 1.0× 1.8k 1.1× 550 0.9× 131 0.3× 90 6.5k
Martin Oft United States 26 2.3k 1.0× 1.7k 1.1× 2.4k 1.6× 490 0.8× 94 0.2× 74 4.8k

Countries citing papers authored by Laurie B. Owen‐Schaub

Since Specialization
Citations

This map shows the geographic impact of Laurie B. Owen‐Schaub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie B. Owen‐Schaub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie B. Owen‐Schaub more than expected).

Fields of papers citing papers by Laurie B. Owen‐Schaub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie B. Owen‐Schaub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie B. Owen‐Schaub. The network helps show where Laurie B. Owen‐Schaub may publish in the future.

Co-authorship network of co-authors of Laurie B. Owen‐Schaub

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie B. Owen‐Schaub. A scholar is included among the top collaborators of Laurie B. Owen‐Schaub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie B. Owen‐Schaub. Laurie B. Owen‐Schaub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hall, Christopher L., Mike Yao, Laurie L. Hill, & Laurie B. Owen‐Schaub. (2004). Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice. Clinical & Experimental Metastasis. 21(3). 251–256. 4 indexed citations
3.
Chandrasekar, Bysani, Rama Mohan Surabhi, Min Li‐Weber, et al.. (2004). Activation of Intrinsic and Extrinsic Proapoptotic Signaling Pathways in Interleukin-18-mediated Human Cardiac Endothelial Cell Death. Journal of Biological Chemistry. 279(19). 20221–20233. 113 indexed citations
4.
Fukazawa, Takuya, Barbara Walter, & Laurie B. Owen‐Schaub. (2003). Adenoviral Bid Overexpression Induces Caspase-dependent Cleavage of Truncated Bid and p53-independent Apoptosis in Human Non-small Cell Lung Cancers. Journal of Biological Chemistry. 278(28). 25428–25434. 22 indexed citations
5.
Guzmán, Esther A., John L. Langowski, & Laurie B. Owen‐Schaub. (2003). Mad dogs, Englishmen and apoptosis: The role of cell death in UV-induced skin cancer. APOPTOSIS. 8(4). 315–325. 51 indexed citations
6.
Owen‐Schaub, Laurie B.. (2002). Fas function and tumor progression: Use it and lose it. Cancer Cell. 2(2). 95–96. 37 indexed citations
7.
Hill, Laurie L., Laurie B. Owen‐Schaub, Darren W. Davis, et al.. (2000). Apoptosis inMycobacterium tuberculosis infection in mice exhibiting varied immunopathology. The Journal of Pathology. 190(2). 211–220. 39 indexed citations
8.
Owen‐Schaub, Laurie B., et al.. (2000). Fas and Fas ligand interactions in malignant disease.. International Journal of Oncology. 17(1). 5–12. 85 indexed citations
9.
Fukazawa, Takuya, Toshiyoshi Fujiwara, Yoshinori Morimoto, et al.. (1999). Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Oncogene. 18(13). 2189–2199. 64 indexed citations
10.
Owen‐Schaub, Laurie B., Wei Zhang, James C. Cusack, et al.. (1995). Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression. Molecular and Cellular Biology. 15(6). 3032–3040. 615 indexed citations breakdown →
11.
Owen‐Schaub, Laurie B., Laura S. Angelo, Robert Radinsky, et al.. (1995). Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?. Cancer Letters. 94(1). 1–8. 94 indexed citations
12.
Owen‐Schaub, Laurie B., Robert Radinsky, Ewa Kruzel, K. K. Berry, & Shin Yonehara. (1994). Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.. PubMed. 54(6). 1580–6. 237 indexed citations
13.
Owen‐Schaub, Laurie B., Shin Yonehara, William L. Crump, & Elizabeth A. Grimm. (1992). DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cellular Immunology. 140(1). 197–205. 345 indexed citations
14.
Grimm, Elizabeth A., Janet M. Bruner, Johannes A. Köppen, et al.. (1991). Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: Growth characteristics, cytolytic activity, and cell phenotype. Cancer Immunology Immunotherapy. 32(6). 391–399. 14 indexed citations
15.
Grimm, Elizabeth A. & Laurie B. Owen‐Schaub. (1991). The IL‐2 mediated amplification of cellular cytotoxicity. Journal of Cellular Biochemistry. 45(4). 335–339. 35 indexed citations
16.
Owen‐Schaub, Laurie B., Maryellen de Mars, Edwin C. Murphy, & Elizabeth A. Grimm. (1990). TNF-beta (lymphotoxin) strongly upregulates TNF-alpha gene expression in human peripheral blood lymphocytes.. PubMed. 9(4). 491–7. 6 indexed citations
17.
Owen‐Schaub, Laurie B., et al.. (1989). Regulation of lymphocyte tumor necrosis factor receptors by IL-2.. The Journal of Immunology. 143(7). 2236–2241. 50 indexed citations
18.
Yang, Stephen C., et al.. (1989). Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-? against primary lung cancer targets. Cancer Immunology Immunotherapy. 29(3). 193–8. 32 indexed citations
19.
Grimm, Elizabeth A., Laurie B. Owen‐Schaub, William G. Loudon, & Masato Yagita. (1988). Lymphokine‐Activated Killer Cells. Annals of the New York Academy of Sciences. 532(1). 380–386. 6 indexed citations
20.
Owen‐Schaub, Laurie B., William G. Loudon, Masato Yagita, & Elizabeth A. Grimm. (1988). Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors. Cellular Immunology. 111(1). 235–246. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026